Scam Alert: We have confirmed that consumers are being solicited to interview for false work-at-home jobs with our company via social media. The scammers are electronically impersonating members of our Human Resources Team and requesting payment for false software. We have reported this scam to the FBI and social media service providers.
Progressive muscular atrophy (PMA), also known as Duchenne-Aran muscular atrophy, is a rare subtype of motor neuron disease. Progressive muscular atrophy only affects the lower motor neurons. It is a sibling condition to amyotrophic lateral sclerosis (ALS), which affects both the upper and lower motor neurons. The distinction is important because PMA is associated with a better prognosis than classic ALS.
Since its initial discovery in 1850, there has been debate in the scientific literature over whether progressive muscular atrophy is a distinct disease with its own characteristics, or if it lies somewhere on a spectrum with ALS.
Symptoms of progressive muscular atrophy include:
Symptoms can be limited to the arms, legs, or both.
Progressive muscular atrophy is a diagnosed through the exclusion of other conditions. There is no specific test that can conclusively establish whether a patient has the condition. Instead, a number of other possibilities have to be ruled out, such as multifocal motor neuropathy or spinal muscular atrophy. Tests used in the diagnostic process include MRI, clinical examination, and EMG.
The prognosis for progressive muscular atrophy is better than with other similar conditions, such as ALS. Those with progressive muscular atrophy have a longer life expectancy than those with ALS. Furthermore, those with progressive muscular atrophy do not suffer from the cognitive change identified in similar conditions. It’s also important to note that an initial diagnosis of PMA could turn out to be slowly progressive ALS many years later, sometimes even decades after the initial diagnosis.
Many with progressive muscular atrophy experience the progressive loss of the ability to walk and position themselves, necessitating the use of a specialized power wheelchair. Quantum Rehab®, the global leader in individualized power chairs, puts an emphasis on mobility technologies specific toward the needs of those with progressive muscular atrophy.
Quantum Power Chairs incorporate power-adjustable seating for user repositioning and comfort; specialty drive controls, including those requiring minimal hand strength; and, a highly-adaptable design to meet an individual’s current and future needs.
Quantum Power Chairs feature the latest advanced technologies to increase the independence of those living with progressive muscular atrophy. iLevel® seat elevation technology allows a user to operate the power chair at seated or standing height. Bluetooth® is also integrated into Quantum’s Q-Logic 3 electronics, so those with progressive muscular atrophy can operate much of their environment with the power chair drive control, itself.
For those with progressive muscular atrophy, Quantum Power Chairs are designed to provide optimal medical comfort and maximum independence. Please click here for more information on Quantum Power Chair solutions for those living with progressive muscular atrophy.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Quantum Rehab is under license. Other trademarks and trade names are those of their respective owners.